Brief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
21/08/2025 12:27
Aug 21 (Reuters) - Hamlet BioPharma AB HAMLETb.TE: HAMLET BIOPHARMA ANNOUNCES COMPLETION OF ALPHA1H PHASE II STUDY IN NON-MUSCLE INVASIVE BLADDER CANCER HAMLET BIOPHARMA AB: ALL PRIMARY & SECONDARY ENDPOINTS OF SAFETY & EFFICACY WERE REACHED Source text: ID:nPn8STH7sa Further company coverage: [HAMLETb.TE] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe